| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |